Navigation Links
Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
Date:2/13/2009

ard-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Cordex are forward-looking statements, including, but not limited to, the statements regarding ATPace's expected entry into a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected commencement of a Phase 2 clinical trial for the treatment of heart failure. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Such risks include the risk that the clinical trial for approval of ATPace and the Phase 2 clinical trial for our CDP-1050 may not be successful, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be successful, and that our technology may not lead to expected results including the development or the successful commercialization of technologies relating to the use of ATP or nitric oxide. Additional uncertainties and risks are described in Cordex's most recently filed SEC documents, such as
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
2. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
3. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
4. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
5. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
6. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
7. Managing Myeloma (www.managingmyeloma.com) Launches - A Comprehensive Information and Educational Site for Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists
8. Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
9. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
10. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
11. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... R.I. (PRWEB) April 01, 2015 After a ... Driving over these potholes can lead to costly damage, so ... vehicle. , Amica is sharing the following suggestions from AAA: ... plenty of tread and be inflated to the manufacturer’s recommended ... in vehicle handling, excessive vibration and uneven tire wear can ...
(Date:4/1/2015)... Taking an important step forward in the ... Commission for Nursing Education Accreditation (NLN CNEA) , the ... CNEA Board of Commissioners. Working with executive director Judith ... will provide leadership and direction to accreditation services and ... nursing programs that seek accreditation from the CNEA. , ...
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... WA (PRWEB) April 01, 2015 ... and patient scheduling platform, today announced that CEO Joel ... 2015 Annual HIMSS Conference & Exhibition in Chicago, ... Revenue Growth with Better Provider Care Coordination Strategies ” ... 16 at 12 p.m. CDT. More than 38,000 healthcare ...
(Date:4/1/2015)... Manistee, Michigan (PRWEB) April 01, 2015 ... visit Best Drug Rehabilitation’s blog, where the latest post ... of last month’s observation of Teen Dating Violence Awareness ... toolkit on this growing problem to help parents identify ... their romantic interest that might involve drugs or alcohol. ...
Breaking Medicine News(10 mins):Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2
... 27 Universal Health Services, Inc. (NYSE: UHS ... or an increase of 14% to $1.37 per diluted share, ... million, or $1.20 per diluted share, during the comparable prior ... an increase of 17% to $1.37 per diluted share, during ...
... Baxter International (NYSE: BAX ), will host ... 11:30 a.m. Eastern Time (10:30 a.m. Central Time)This call is ... Web site at http://www.baxter.com/ . ... is copyrighted material. It cannot be recorded or rebroadcast ...
... to avoid "non-essential" travel to Mexico City BALTIMORE, April ... A (H1N1) virus infections in the U.S., top officials ... any chances," said Fran Lessans, CEO of Passport Health, ... immunizations. "We are warning travelers to postpone their trips ...
... WASHINGTON, April 27 The American Public Health Association (APHA) ... as an opportunity to ensure that they and their families ... emergencies that may arise."Although it is far too early to ... warrants alarm, the number of cases and the speed with ...
... April 27 The Center for Disease Control ... swine influenza A (H1N1) virus in the United ... the outbreak a "public health emergency of international ... offices, hospital clinics, and emergency rooms prepare to ...
... 27 Nestled in the heart of one of the ... Center (HPMC) is reaching out to families throughout the city ... home; a place that is comfortable and secure, night and ... community based on the simple principle of trust," said Jim ...
Cached Medicine News:Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 2Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 3Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 4Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 5Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 6Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 7Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 8Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 9Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 10Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 11Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 12Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 13Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 14Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 15Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 16Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 17Health News:Swine Flu Spreads 2Health News:Swine Flu Reinforces the Importance of Preparing for Emergencies, Says APHA 2Health News:Copan Diagnostics, Inc. Offers Kit for Rapid Collection of Nasopharyngeal Sample to Detect Swine Flu Virus 2Health News:Hollywood Presbyterian Medical Center: Taking the Message of Trust to the Streets of LA 2
(Date:4/1/2015)... what is a first formal tie-up for the two organizations, ... are co-organizing the BPMDS Symposium China Forum ... China South 2015 exhibition at Shenzhen Convention & Exhibition Center. ... device manufacturers in going abroad. This is the ... China . Furthermore, MEDTEC China South will provide ...
(Date:4/1/2015)... HONG KONG , April 1, 2015 ... stock code: 2211) announced that Mr. Jin Dongtao, chairman ... of the Company, representing 2% of the existing entire ... Limited, at HK$2.82 per share with the total amount ... transaction, Mr. Jin Dongtao,s shareholding will increase from 45.17% ...
(Date:4/1/2015)... April 1, 2015  Medelita® has renewed a commitment ... United States who have exhibited leadership in ... In its inaugural year, "The Right Fit H.E.R.O. Honorarium" ... nominations were narrowed to 10 through a series of ... 10,000 votes from colleagues in medicine, friends, and family.  ...
Breaking Medicine Technology:MEDTEC & NAMSA Co-organize BPMDS Symposium China 2MEDTEC & NAMSA Co-organize BPMDS Symposium China 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4
... LISBON, Portugal, September 11 , ... New Intranasal Treatment,for Breakthrough Cancer Pain Over OTFC , ... efficacy of Instanyl in,management of breakthrough cancer pain. The data ... of Chapters of the International,Association for the Study of Pain ...
... , , Letters of Intent due ... DES PLAINES, Ill., Sept. 10 The American Brain Tumor Association has launched ... ideas for solving the challenges of brain tumor diagnosis and treatment. , ... the past decade resulting in better treatments and longer lives for many patients, ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4American Brain Tumor Association Calls for Discovery Research 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: